BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12667227)

  • 1. Treatment perspectives for human African trypanosomiasis.
    Bouteille B; Oukem O; Bisser S; Dumas M
    Fundam Clin Pharmacol; 2003 Apr; 17(2):171-81. PubMed ID: 12667227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of human African trypanosomiasis--present situation and needs for research and development.
    Legros D; Ollivier G; Gastellu-Etchegorry M; Paquet C; Burri C; Jannin J; Büscher P
    Lancet Infect Dis; 2002 Jul; 2(7):437-40. PubMed ID: 12127356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy against human African trypanosomiasis: is there a road to success?
    Burri C
    Parasitology; 2010 Dec; 137(14):1987-94. PubMed ID: 20961469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of human African trypanosomiasis.
    Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
    Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for second-stage Human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2010 Aug; (8):CD006201. PubMed ID: 20687080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis.
    Babokhov P; Sanyaolu AO; Oyibo WA; Fagbenro-Beyioku AF; Iriemenam NC
    Pathog Glob Health; 2013 Jul; 107(5):242-52. PubMed ID: 23916333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The continuing problem of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Ann Neurol; 2008 Aug; 64(2):116-26. PubMed ID: 18756506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for second-stage human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006201. PubMed ID: 23807762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African sleeping sickness.
    Hedley L; Fink D; Sparkes D; Chiodini PL
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
    [No Abstract]   [Full Text] [Related]  

  • 17. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative form of melarsoprol in sleeping sickness.
    Kennedy PG
    Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.